Clinical observation of treatment in ovary endometriosis with mifepristone after laparoscopic surgery
10.3760/cma.j.issn.1673-4904.2010.03.007
- VernacularTitle:腹腔镜手术后应用米非司酮治疗子宫内膜异位症的临床疗效
- Author:
Genlian GUO
;
Xiangjun CHEN
- Publication Type:Journal Article
- Keywords:
Endometriosis;
Mffepristone;
Gestrinone;
Laparoscopy
- From:
Chinese Journal of Postgraduates of Medicine
2010;33(3):16-18
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the role of mifepristone in endometriosis after laparoscopic surgery. Methods One hundred and forty-three women diagnosed with endometriosis after laparoscopic surgery were divided into two groups: one group with 78 cases were given mifepristone at 10 mg once daily (mifepristone group),and the other group with 65 cases were given gestrinone at 2.5 mg,twice every week (gestrinone group). All patients were followed-up 1 to 2 years and observed curative effect, compared the therapy effect on endometriosis as well as the side effects of two drugs. Results The clinical symptom and sign were improved at 3, 6, 12 months in two groups (P< 0.01). The rate of efficiency was 85.9%(67/78) in mifepristone group,and 84.6%(55/65) in gestrinone group, there was no significant difference between two groups (P > 0.05). The rates of acne, weight gain, joint ache, aminotransferase increase was lower in mifepristone group than those in gestrinone group (P <0.01 or <0.05). The recovery time of ovulation or menstruation was shorter in mifepristone group [(12.0 ± 2.9), (26.8 ± 3.9) d]than those in gestrinone group [(25.3 ±3.7), (35.0±4.1) d](P<0.05). Conclusions Mifepristone seems to be an effective,safe,and convenient treatment for endometriosis with low-cost and few side effects. Therefore,it can be used as first choice for treatment of endometriosis after laparoscopic surgery.
